杨群智 , 张舸 , 费雅楠 , 付爽 , 闫冰 . 沙利度胺治疗原发性干燥综合征合并轻中度非特异性间质性肺炎疗效观察[J]. 北京大学学报（医学版）, 2021 , 53(2) : 413 -416 . DOI: 10.19723/j.issn.1671-167X.2021.02.030
| [1] | 董笑影, 魏蔚. 沙利度胺治疗肺纤维化新进展[J]. 天津医科大学学报, 2015(3):272-274. |
| [2] | 李丹, 刘学军, 杜毓峰. 沙利度胺治疗肺间质纤维化疗效的系统评价[J]. 国际呼吸杂志, 2014,34(14):1069-1074. |
| [3] | Warrick J, Bhalla M, Schabel S, et al. High resolution computed tomography in early scleroderma lung disease[J]. J Rheumatol, 1991,18(10):1520-1528. |
| [4] | Nicholson AG, Colby TV, Wells AU. Histopathological approach to patterns of interstitial pneumonia in patient with connective tissue disorders[J]. Sarcoidosis Vasc Diffuse Lung Dis, 2002,19(1):10-17. |
| [5] | 郭强, 鲍春德. 结缔组织病与肺间质病变进展[J]. 上海医学, 2009,32(10):918-923. |
| [6] | Povysil C. Histopathological classification of idiopathic interstitial pneumonias[J]. Cesk Patol, 2010,46(1):3-7. |
| [7] | Kim DI, Lim YJ, Oh YH, et al. A case of Sj?gren’s syndrome with multiple bullae secondary to pulmonary amyloidosis and lymphocytic infiltration of interstitium and bronchioles[J]. Tuberculosis & Respiratory Diseases, 1997,44(6):1426-1432. |
| [8] | Ito I, Nagai S, Kitaichi M, et al. Pulmonary manifestations of primary Sj?gren’s syndrome: A clinical, radiologic, and pathologic study[J]. Am J Respir Crit Care Med, 2005,171(6):632-638. |
| [9] | 徐慧蓉, 马小兵, 王献华, 等. 肺纤维化相关因子研究进展[J]. 现代预防医学, 2011,38(10):1953-1955. |
| [10] | Zielonka TM. Angiogenesis in interstitial lung diseases[J]. Pneumonol Alergol Pol, 2009,77(1):52-60. |
| [11] | Okuma T, Terasaki Y, Kaikita K, et al. C-C chemokine receptor 2 (CCR2) deficiency improves bleomycin-induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage-derived matrix metalloproteinases[J]. J Pathol, 2004,204(5):594-604. |
| [12] | Tabata C, Tabata R, Takahashi Y, et al. Thalidomide prevents cigarette smoke extract-induced lung damage in mice[J]. Int Immunopharmacol, 2015,25(2):511-517. |
| [13] | Arai H, Furusu A, Nishino T, et al. Thalidomide prevents the progression of peritoneal fibrosis in mice[J]. Acta Histochem Cytochem, 2011,44(2):51-60. |
| [14] | Leiba M, Avigdor A. Bortezomib, thalidomide and dexamethasone versus bortezomib, cyclophosphamide and dexamethasone as induction therapy prior to ASCT in multiple myeloma: Response to Moreau[J]. Br J Haematol, 2015,168(4):604-605. |
| [15] | 李冬, 徐丽艳, 常子娟, 等. 沙利度胺对百草枯诱导小鼠急性肺损伤的干预[J]. 中华劳动卫生职业病杂志, 2013,31(3):178-183. |
| [16] | Buckstein R, Kerbel R, Cheung M, et al. Lenalidomide and metronomic melphalan for CMML and higher risk MDS: A phase 2 clinical study with biomarkers of angiogenesis[J]. Leuk Res, 2014,38(7):756-763. |
| [17] | Tan H, Chen H, Xu C, et al. Role of vascular endothelial growth factor in angiodysplasia: An interventional study with thalidomide[J]. J Gastroenterol Hepatol, 2012,27(6):1094-1101. |
| [18] | Lechtzin N, Hilliard ME, Horton MR. Validation of the cough quality-of-life questionnaire in patients with idiopathic pulmonary fibrosis[J]. Chest, 2013,143(6):1745-1749. |
| [19] | Horton MR, Santopietro V, Mathew L, et al. Thalidomide for the treatment of cough in idiopathic, pulmonary fibrosis: A randomized trial[J]. Ann Intern Med, 2012,157(6):398-406. |
| [20] | Gay SE, Kazerooni EA, Toews GB, et al. Idiopathic pulmonary fibrosis: Predicting response to therapy and survival[J]. Am J Respir Crit Care Med, 1998,157(4 Pt 1):1063-1072. |
| [21] | Dixon S, Benamore R. The idiopathic interstitial pneumonias: Understanding key radiological features[J]. Clin Radiol, 2010,65(10):823-831. |
/
| 〈 |
|
〉 |
